Esper Bionics develops and manufactures bionic upper-limb prosthetics (notably the Esper Hand) designed to restore physical function and economic independence for amputees. Its products enable users to perform complex work tasks and engage in active lifestyles, and the company highlights design features that improve usability for many female amputees. The Esper Hand has won awards including the Red Dot “Best of the Best,” a Time magazine Best Innovations recognition, and a CES Innovation Award. Esper plans to expand its operations in Ukraine and grow global sales while later developing and launching lower-limb prosthetics. Current financing is intended to expand production facilities and fund new products and software to broaden the company’s offerings. The company’s mission emphasizes supporting war veterans and other amputees’ rehabilitation and reintegration into the workforce.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Jun 2024